Most importantly, there was no clear OS benefit for all LT(+) patients, but a notable trend was observed and further analysis identified subgroups with a substantial benefit of LT during sequential MT.
← all excerpts
Impact of local therapy in metastatic renal cell carcinoma during medical treatment in a retrospective analysis.
1
—
—